Metabolism, metabolites, and macrophages in cancer

M Li, Y Yang, L Xiong, P Jiang, J Wang, C Li - Journal of hematology & …, 2023 - Springer
Tumour-associated macrophages (TAMs) are crucial components of the tumour
microenvironment and play a significant role in tumour development and drug resistance by …

Harnessing tumor-associated macrophages as aids for cancer immunotherapy

X Li, R Liu, X Su, Y Pan, X Han, C Shao, Y Shi - Molecular Cancer, 2019 - Springer
Cancer immunotherapies that engage immune cells to fight against tumors are proving to be
powerful weapons in combating cancer and are becoming increasingly utilized in the clinics …

CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies

TNJ Bullock - Cellular & molecular immunology, 2022 - nature.com
The substantial advances attained by checkpoint blockade immunotherapies have driven an
expansion in the approaches used to promote T cell access to the tumor microenvironment …

Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma

MT Patterson, AL Burrack, Y Xu, GH Hickok… - Cell reports, 2023 - cell.com
Pancreatic ductal adenocarcinoma (PDA) orchestrates a suppressive tumor
microenvironment that fosters immunotherapy resistance. Tumor-associated macrophages …

Tumor-associated macrophages in pancreatic ductal adenocarcinoma: therapeutic opportunities and clinical challenges

AR Poh, M Ernst - Cancers, 2021 - mdpi.com
Simple Summary Macrophages are a major component of the pancreatic tumor
microenvironment, and their increased abundance is associated with poor patient survival …

Targeting tumor-associated macrophages in cancer immunotherapy

AJ Petty, DH Owen, Y Yang, X Huang - Cancers, 2021 - mdpi.com
Simple Summary Tumor-associated macrophages (TAMs) coinhabit the tumor
microenvironment with cancer, immune, and stromal cells. They undermine the immune …

Concepts for agonistic targeting of CD40 in immuno-oncology

DM Richards, JP Sefrin, C Gieffers, O Hill… - Human vaccines & …, 2020 - Taylor & Francis
ABSTRACT TNF Receptor Superfamily (TNF-R-SF) signaling is a structurally well-defined
event that requires proper receptor clustering and trimerization. While the TNF-SF ligands …

Preclinical models of pancreatic ductal adenocarcinoma and their utility in immunotherapy studies

TND Pham, MA Shields, C Spaulding, DR Principe… - Cancers, 2021 - mdpi.com
Simple Summary Immune checkpoint blockade has provided durable clinical responses in a
number of human malignancies, but not in patients with pancreatic cancer. Efforts to …

[HTML][HTML] Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer

AL Burrack, ZC Schmiechen, MT Patterson, EA Miller… - JCI insight, 2022 - ncbi.nlm.nih.gov
We investigate how myeloid subsets differentially shape immunity to pancreatic ductal
adenocarcinoma (PDA). We show that tumor antigenicity sculpts myeloid cell composition …

[HTML][HTML] Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer

IM Stromnes, A Hulbert, MR Rollins… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Achieving robust responses with adoptive cell therapy for the treatment of the
highly lethal pancreatic ductal adenocarcinoma (PDA) has been elusive. We previously …